title: [ESC/EAS Guidelines for the management of dyslipidaemias].
authors: University Hospital Center Zagreb, School of Medicine, University of Zagreb, Salata 2, 10 000 Zagreb, Croacia. zreiner@kbc-zagreb.hr
authors: Željko
authors: Ž
authors: Reiner
authors: Alberico L
authors: AL
authors: Catapano
authors: Guy
authors: G
authors: De Backer
authors: Ian
authors: I
authors: Graham
authors: Marja-Riitta
authors: MR
authors: Taskinen
authors: Olov
authors: O
authors: Wiklund
authors: Stefan
authors: S
authors: Agewall
authors: Eduardo
authors: E
authors: Alegría
authors: M John
authors: MJ
authors: Chapman
authors: Paul
authors: P
authors: Durrington
authors: Serap
authors: S
authors: Erdine
authors: Julian
authors: J
authors: Halcox
authors: Richard Hobbs
authors: RH
authors: Hobbs
authors: John Kjekshus
authors: JK
authors: Kjekshus
authors: Pasquale
authors: P
authors: Perrone Filardi
authors: Gabriele
authors: G
authors: Riccardi
authors: Robert F
authors: RF
authors: Storey
authors: Wood
authors: W
authors: David
mesh_terms: D000465:Algorithms; D002318:Cardiovascular Diseases / Q000517:prevention & control; D050171:Dyslipidemias / Q000188:drug therapy / Q000191:economics / Q000628:therapy*; D006040:Goals; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008055:Lipids / Q000097:blood; D018570:Risk Assessment; D013030:Spain
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D008055:Lipids